Some studies have shown that CD8+ T cells activated by immunotherapy enhance ferroptosis-specific lipid peroxidation in tumor cells, and the increase of ferroptosis contributes to the anti-tumor efficacy of immunotherapy. The gene discussed is CD8A; the disease is neoplasm.